We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic Acid Science (ISHAS) as an inaugural member of the Advisory Board (AAB). ISHAS is a prestigious organization whose mission is to promote research, organize the publication of scientific reports and disseminate knowledge about the hyaluronic acid molecule, its structure, function, and therapeutic applications.
This partnership is more than just a strategic collaboration. ISHAS will benefit from SyrHA’s practical industry experience as a biotech medical device company and as a global leader in providing innovative medical devices solutions for aesthetics, orthopedics, ophthalmology, and dermatology. SyrHA stands to gain substantial benefits from engaging with top-tier research and a prominent expert network.
By leveraging the synergy between state-of-the-art research and a global community of experts, SyrHA can consolidate its leadership position in the CDMO world, delivering exceptional value to its customers and stakeholders.
Collaboration with leading scientists and researchers will foster the development of new products and services, and enhance existing ones, ensuring that SyrHA remains at the forefront of progress. Moreover, integration into a network of international experts provides an invaluable exchange of ideas, access to a wider range of specialist knowledge, and the opportunity to form strategic partnerships. These collaborations will improve efficiency, optimize manufacturing processes and create more sophisticated products.
Learn more about this initiative:
SyrHA is specialized in the manufacture of medical devices, in the form of pre-filled syringes. We are a Swiss CDMO, and we manufacture aesthetic medical devices.
We also develop hydrogel products for orthopedics, ophthalmology and dermatology.
Do you have a project?
